SCM
ELV icon

SeaStone Capital Management’s Elevance Health ELV Stock Holding History

SeaStone Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$10.8M Sell
77,733
-59,427
-43% -$7.94M 12.4% 2
2015
Q4 		$19.1M Buy
+137,160
New +$18.9M 6.62% 3

Other funds holding ELV

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

SeaStone Capital Management's ELV Position: Q1 2016 in Review

SeaStone Capital Management reduced its Elevance Health (ELV) stake by 43% in Q1 2016, selling an estimated $7.94M and leaving 77,733 shares worth $10.8M. The position accounts for 12.4% of the portfolio, ranked #2.

SeaStone Capital Management first reported a position in ELV in Q4 2015 and has held it in 2 quarters since. The position peaked at $19.1M in Q4 2015. 770 funds tracked by Wall St. Rank hold ELV as of Q1 2016.

  • SeaStone Capital Management held 77,733 shares of Elevance Health worth $10.8M as of Q1 2016.
  • SeaStone Capital Management sold 59,427 Elevance Health shares in Q1 2016, an estimated $7.94M.
  • Elevance Health made up 12.4% of SeaStone Capital Management's portfolio in Q1 2016, its #2 holding.
  • SeaStone Capital Management first reported a position in Elevance Health in Q4 2015 and has held it in 2 quarters since.
  • SeaStone Capital Management's Elevance Health position peaked at $19.1M in Q4 2015.
  • 770 funds tracked by Wall St. Rank held Elevance Health as of Q1 2016.

Based on SeaStone Capital Management's 13F filing for Q1 2016, filed 16 May 2016.